Skip to main content

ForteBio Hires Octet Distributors in Australia, New Zealand, and Switzerland

NEW YORK (GenomeWeb News) — ForteBio, a developer of label-free, real-time systems for biomolecular interaction analysis, this week said it has hired two distributors to sell its Octet instruments and related consumables in parts of Europe and the South Pacific.
Swiss company Bucher Biotec will exclusively distribute ForteBio’s products in that country, while Millennium Science, an Australian distributor, will sell the products in that nation and in neighboring New Zealand.
ForteBio CEO Winnie Wan said in a statement that the distribution deals “will accelerate our efforts to further penetrate and serve these key markets,” which have shown a “growing demand for label-free solutions that are flexible, cost-efficient and accurate.”
The company’s Octet tools are “designed to help accelerate the selection and characterization of therapeutic candidates by generating real-time kinetic and quantitative results quickly and easily,” ForteBio said in the statement.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.